SCHEMBL3963684

SCHEMBL3963684

C=CCOc1cc(C)cc(O)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 1/20 0.45
ALDH1A1 P00352 3/20 0.43
SLC5A1 P13866 1/20 0.41
SLC5A2 P31639 1/20 0.41
GAA P10253 5/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PTPN1 P18031 1/20 0.39
POLB P06746 1/20 0.38
HPGD P15428 3/20 0.38
MGAM O43451 3/20 0.37
SI P14410 3/20 0.37
MGAM2 Q2M2H8 3/20 0.37
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Orcinol SCHEMBL6931140 0.98 KAT6A (0.44) KAT6AALDH1A1SLC5A1SLC5A2GAA
SCHEMBL8385349 0.96 ALDH1A1 (0.48) KAT6AALDH1A1SLC5A1SLC5A2GAA
SCHEMBL16015475 0.86 SLC5A1 (0.46) ALDH1A1SLC5A1SLC5A2GAAMAPT
SCHEMBL3595767 0.86 ALDH1A1 (0.41) KAT6AALDH1A1GAAMAPTMEN1
SCHEMBL18984966 0.86 SLC5A1 (0.46) ALDH1A1SLC5A1SLC5A2GAAMAPT
SCHEMBL3968437 0.81 GAA (0.50) ALDH1A1SLC5A1SLC5A2GAAMAPT
SCHEMBL4880814 0.79 KAT6A (0.41) KAT6AALDH1A1SLC5A1SLC5A2GAA
Metacresol SCHEMBL8384132 0.78 ACHE (0.53) ALDH1A1GAAMAPTMEN1LMNA
SCHEMBL12658254 0.78 MAPT (0.38) KAT6AALDH1A1GAAMAPTMEN1
SCHEMBL17204539 0.78 GAA (0.40) KAT6AALDH1A1GAAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10029992-B2 Diaminotriazine compounds and their use as herbicides BASF SE (DE) 2018-07-24 US claimed
EP-3134391-A1 DIAMINOTRIAZINE COMPOUNDS AND THEIR USE AS HERBICIDES BASF SE (DE) 2017-03-01 EP claimed
US-20170044114-A1 Diaminotriazine compounds and their use as herbicides BASF SE (DE) 2017-02-16 US claimed
WO-2015162166-A1 DIAMINOTRIAZINE COMPOUNDS AND THEIR USE AS HERBICIDES BASF SE (DE) 2015-10-29 WO claimed
US-10029992-B2 Diaminotriazine compounds and their use as herbicides BASF SE (DE) 2018-07-24 US disclosed
EP-3134391-A1 DIAMINOTRIAZINE COMPOUNDS AND THEIR USE AS HERBICIDES BASF SE (DE) 2017-03-01 EP disclosed
US-20170044114-A1 Diaminotriazine compounds and their use as herbicides BASF SE (DE) 2017-02-16 US disclosed
CN-106232586-A Diaminotriazine compounds and their use as herbicides 巴斯夫欧洲公司 2016-12-14 CN disclosed
WO-2015162166-A1 DIAMINOTRIAZINE COMPOUNDS AND THEIR USE AS HERBICIDES BASF SE (DE) 2015-10-29 WO disclosed
EP-1363876-B1 GLUCOCORTICOID RECEPTOR MODULATORS KAROBIO AB (SE) 2009-07-29 EP disclosed
US-6583180-B2 Antidiabetic agents ABBOTT LABORATORIES 2003-06-24 US disclosed
US-20020156311-A1 Glucocorticoid receptor modulators KARO BIO AB (SE) 2002-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156311-A1 Glucocorticoid receptor modulators NR3C1, NR5A1, NR3C2 KAT6A 2689/4885ALDH1A1 1310/4885SLC5A1 13/4885
US-10029992-B2 Diaminotriazine compounds and their use as herbicides NR4A3, CBR3, RCOR3 KAT6A 1026/4885ALDH1A1 941/4885SLC5A1 1866/4885
US-20170044114-A1 Diaminotriazine compounds and their use as herbicides NR4A3, CBR3, RCOR3 KAT6A 1028/4885ALDH1A1 935/4885SLC5A1 1881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.